Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ · Healthcare
Orchestra BioMed Holdings, Inc. Shareholder Equity 2022–2025
Orchestra BioMed Holdings, Inc. annual/quarterly shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Orchestra BioMed Holdings, Inc. shareholder equity for the quarter ending December 31, 2025 were 53.6M, a 62.54% increase year-over-year.
- Orchestra BioMed Holdings, Inc. shareholder equity for 2025 were 53.6M, a 62.54% increase from 2024.
- Orchestra BioMed Holdings, Inc. shareholder equity for 2024 were 33.0M, a 51.56% decrease from 2023.
- Orchestra BioMed Holdings, Inc. shareholder equity for 2023 were 68.0M, a 29.52% increase from 2022.
- Orchestra BioMed Holdings, Inc. shareholder equity for 2022 were 52.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Orchestra BioMed Holdings, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $54 |
| 2024 | $33 |
| 2023 | $68 |
| 2022 | $53 |
| Orchestra BioMed Holdings, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $54 |
| 2024-12-31 | $33 |
| 2023-12-31 | $68 |
| 2022-12-31 | $53 |
Orchestra BioMed Holdings, Inc. Shareholder Equity — FAQ
Orchestra BioMed Holdings, Inc. (OBIO) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OBIO's shareholder equity history?
The chart and table above show Orchestra BioMed Holdings, Inc.'s shareholder equity by year and by quarter, including the growth rate.